Quantitation_NN
of_IN
beta_NN
1_CD
triiodothyronine_NN
receptor_NN
mRNA_NN
in_IN
human_JJ
tissues_NNS
by_IN
competitive_JJ
reverse_JJ
transcription_NN
polymerase_NN
chain_NN
reaction_NN
._.

Thyroid_NN
hormones_NNS
act_VBP
by_IN
binding_NN
to_TO
nuclear_JJ
receptor_NN
proteins_NNS
,_,
the_DT
thyroid_NN
hormone_NN
receptors_NNS
-LRB-_-LRB-
TR_NN
-RRB-_-RRB-
alpha_NN
and_CC
beta_NN
._.

Data_NNS
from_IN
cell_NN
culture_NN
and_CC
animal_JJ
studies_NNS
indicate_VBP
that_IN
TR_NN
expression_NN
may_MD
be_VB
regulated_VBN
to_TO
modulate_VB
target_NN
organ_NN
responsiveness_NN
to_TO
thyroid_NN
hormone_NN
._.

To_TO
investigate_VB
whether_IN
such_JJ
adaptive_JJ
changes_NNS
in_IN
TR_NN
expression_NN
occur_VBP
in_IN
humans_NNS
,_,
we_PRP
determined_VBD
the_DT
mRNA_NN
levels_NNS
of_IN
the_DT
hTR_NN
beta_NN
1_CD
in_IN
various_JJ
thyroid_NN
states_NNS
._.

Patients_NNS
with_IN
overt_JJ
hypo_NN
-_:
or_CC
hyperthyroidism_NN
were_VBD
enrolled_VBN
in_IN
the_DT
study_NN
._.

Total_JJ
RNA_NN
was_VBD
isolated_VBN
from_IN
peripheral_JJ
blood_NN
mononuclear_JJ
cells_NNS
and_CC
hTR_NN
beta_NN
1_CD
mRNA_NN
levels_NNS
determined_VBN
by_IN
quantitative_JJ
competitive_JJ
reverse_JJ
transcription_NN
PCR_NN
._.

For_IN
comparison_NN
,_,
hTR_NN
beta_NN
1_CD
mRNA_NN
levels_NNS
were_VBD
determined_VBN
in_IN
lymphocytes_NNS
and_CC
normal_JJ
thyroid_NN
tissue_NN
of_IN
euthyroid_JJ
patients_NNS
._.

Human_JJ
TR_NN
beta_NN
1_CD
mRNA_NN
levels_NNS
in_IN
lymphocytes_NNS
were_VBD
1.8_CD
+_CC
\/_CD
-_TO
0.4_CD
,_,
1.9_CD
+_CC
\/_CD
-_:
0.5_CD
,_,
1.1_CD
+_CC
\/_CD
-_:
0.4_CD
10_CD
-LRB-_-LRB-
-18_CD
-RRB-_-RRB-
mol\/microgram_NN
RNA_NN
in_IN
hypo_NN
-_:
,_,
eu_NN
-_:
and_CC
hyperthyroid_JJ
patients_NNS
,_,
respectively_RB
,_,
corresponding_VBG
to_TO
an_DT
estimated_VBN
0.5_CD
-_:
2_CD
molecules_NNS
per_IN
cell_NN
._.

Although_IN
the_DT
mean_NN
hTR_NN
beta_NN
1_CD
mRNA_NN
levels_NNS
were_VBD
40_CD
%_NN
lower_JJR
in_IN
hyperthyroid_JJ
than_IN
in_IN
euthyroid_JJ
subjects_NNS
,_,
this_DT
difference_NN
did_VBD
not_RB
reach_VB
statistical_JJ
significance_NN
._.

Similar_JJ
levels_NNS
of_IN
hTR_NN
beta_NN
1_CD
mRNA_NN
levels_NNS
were_VBD
detected_VBN
in_IN
thyroid_NN
gland_NN
from_IN
euthyroid_JJ
patients_NNS
._.

In_IN
summary_NN
,_,
we_PRP
developed_VBD
an_DT
assay_NN
for_IN
the_DT
quantitative_JJ
determination_NN
of_IN
hTR_NN
beta_NN
1_CD
mRNA_NN
levels_NNS
in_IN
small_JJ
human_JJ
tissue_NN
samples_NNS
,_,
containing_VBG
as_RB
little_JJ
as_IN
50_CD
ng_NN
of_IN
total_JJ
RNA_NN
._.

Absolute_JJ
hTR_NN
beta_NN
1_CD
mRNA_NN
levels_NNS
are_VBP
very_RB
low_JJ
with_IN
an_DT
estimated_VBN
one_CD
molecule_NN
of_IN
mRNA_NN
being_VBG
present_JJ
in_IN
a_DT
mononuclear_JJ
blood_NN
cell_NN
or_CC
thyrocyte_NN
._.

No_DT
up-regulation_NN
of_IN
hTR_NN
beta_NN
1_CD
was_VBD
seen_VBN
in_IN
hypothyroid_JJ
relative_JJ
to_TO
euthyroid_JJ
patients_NNS
._.

However_RB
,_,
there_EX
is_VBZ
a_DT
non-significant_JJ
trend_NN
towards_IN
a_DT
down-regulation_NN
of_IN
hTR_NN
beta_NN
1_CD
mRNA_NN
levels_NNS
in_IN
hyperthyroid_JJ
patients_NNS
._.

